Acoustic Wave Cell Therapy, Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$10M
Investors
17
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Acoustic Wave Cell Therapy, Inc. is a Delaware corporation that filed a Form D with the SEC on November 13, 2023 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Acoustic Wave Cell Therapy, Inc. reported $10,426,093 sold from 17 investors of a $15,000,000 total offering as of the Form D filed November 13, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 17639 Sherman Way, Suite 125, Van Nuys, CA 91406.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
3
closed, lapsed
Investor
- 3 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2023-11-13: 1 related person added and 0 removed against the filing of 2019-02-08; 4 now listed. The names are in the Terminal feed.
CHARLES ENGLES
Executive Officer, Director · Van Nuys, CA
Chief Executive Officer
PAUL MACCASKILL
Director · Van Nuys, CA
TOM LUE
Director · Van Nuys, CA
CHIAHUI WANG
Director · Van Nuys, CA
Questions About Acoustic Wave Cell Therapy, Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Acoustic Wave Cell Therapy, Inc.?
Acoustic Wave Cell Therapy, Inc. is a Delaware corporation that filed a Form D with the SEC on November 13, 2023 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.
Is Acoustic Wave Cell Therapy, Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. Acoustic Wave Cell Therapy, Inc. filed a Form D with the SEC on November 13, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $10,426,093 sold to 17 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Acoustic Wave Cell Therapy, Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Acoustic Wave Cell Therapy, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Acoustic Wave Cell Therapy, Inc. raised?
Acoustic Wave Cell Therapy, Inc. reported $10,426,093 sold from 17 investors of a $15,000,000 total offering as of the Form D filed November 13, 2023.
Who can invest in Acoustic Wave Cell Therapy, Inc.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Acoustic Wave Cell Therapy, Inc.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Acoustic Wave Cell Therapy, Inc. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind Acoustic Wave Cell Therapy, Inc.?
The Form D lists 4 related persons: CHARLES ENGLES, executive officer, director (Chief Executive Officer); PAUL MACCASKILL, director; TOM LUE, director; CHIAHUI WANG, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Acoustic Wave Cell Therapy, Inc. located?
The issuer's address on its SEC filings is 17639 Sherman Way, Suite 125, Van Nuys, CA 91406. Its phone number of record is 650-851-7358. It is organized under the laws of Delaware.
How long is the Acoustic Wave Cell Therapy, Inc. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is Acoustic Wave Cell Therapy, Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.